Hansa Biopharma to host Capital Markets Day on Thursday October 29, 2020 in Copenhagen

Rhea-AI Summary

Hansa Biopharma will hold its 2020 Capital Markets Day on October 29 in Copenhagen. Scheduled for 13:30-17:30 CET (7:30am-11:30am EST), the event aims to showcase Hansa's evolution into a commercial biopharmaceutical entity. The focus will be on the company's antibody-cleaving enzyme platform, exploring its applications in autoimmunity and gene therapy beyond transplantation. While a limited number of attendees can participate in-person due to COVID-19, the event will be livestreamed for broader accessibility. Registrants will receive a detailed agenda later.

LUND, Sweden, Sept. 17, 2020 /PRNewswire/ -- Hansa Biopharma ("Hansa"), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company will host its 2020 Capital Markets Day (CMD) in Copenhagen on Thursday October 29, from 13:30-17:30 CET (7:30am-11:30am EST).

The CMD event will be focused around Hansa Biopharma's transformation into a fully integrated and commercial stage biopharmaceutical company and will highlight the potential of the Company's unique antibody-cleaving enzyme platform beyond transplantation in areas such as autoimmunity and gene therapy. 

The event will feature both senior management and external guest speakers. A detailed agenda is expected to be shared to registrants a few weeks ahead of the CMD. The event will be livestreamed and available for all viewers on our web at http://www.hansabiopharma.com. 

If you wish to participate in the CMD virtually, kindly sign up using the following link here.

Due to the COVID-19 pandemic, there will be limitations to the number of physical participants at the CMD. In-person invitations will go out separetaly by email to select institutional investors, analysts and media.

CONTACT:

For further information, please contact:

Klaus Sindahl, Head of Investor Relations
Hansa Biopharma 
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com  

Katja Margell
Head of Corporate Communications
Hansa Biopharma 
Mobile: +46 (0) 768-198 326
E-mail: katja.margell@hansabiopharma.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-host-capital-markets-day-on-thursday-october-29--2020-in-copenhagen,c3195056

The following files are available for download:

https://mb.cision.com/Main/1219/3195056/1306923.pdf

Release

 

View original content:http://www.prnewswire.com/news-releases/hansa-biopharma-to-host-capital-markets-day-on-thursday-october-29-2020-in-copenhagen-301132926.html

SOURCE Hansa Biopharma AB

FAQ

When is Hansa Biopharma's Capital Markets Day in 2020?

Hansa Biopharma's Capital Markets Day is scheduled for October 29, 2020.

Where will the Hansa Biopharma Capital Markets Day be held?

The Capital Markets Day will take place in Copenhagen.

What time does Hansa Biopharma's Capital Markets Day start?

The event starts at 13:30 CET (7:30am EST).

Can I attend Hansa Biopharma's Capital Markets Day virtually?

Yes, Hansa Biopharma's Capital Markets Day will be livestreamed for virtual attendees.

What topics will be discussed at Hansa Biopharma's Capital Markets Day?

The CMD will cover Hansa's transition to a commercial biopharmaceutical company and its antibody-cleaving enzyme platform's potential applications.

Are there any attendance limitations for Hansa Biopharma's Capital Markets Day?

Yes, due to COVID-19, in-person attendance is limited to select institutional investors, analysts, and media.